1-(2--羟乙基)-5-巯基-1H-四氮唑 | 56610-81-2

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1-(2--羟乙基)-5-巯基-1H-四氮唑
• 中文别名: 1-(2-羟基)乙基-1H-5-巯基-四氮唑；氟氧头孢3位侧链；2-(5-巯基-四氮唑-1基)乙醇；1-羟乙基-5-巯基-四氮唑；β-(5-巯基-1H-四氮唑-1)-乙醇；5-巯基-1H-四氮唑乙醇；1-羟乙基-5-巯基-1H-四氮唑；1-(2-羟基乙基)-5-巯基-1H-四氮唑；MTE
• 英文名称: 1-(2-hydroxyethyl)-5-mercapto-1H-tetrazole
• 英文别名: 1-(2-hydroxyethyl)-5-mercaptotetrazole；1-(2-hydroxyethyl)-2H-tetrazole-5-thione
• CAS: 56610-81-2
• 化学式: C₃H₆N₄OS
• 分子量: 146.173
• InChiKey: YKYUEQRWYGVUKB-UHFFFAOYSA-N

物化性质

• 熔点：
  132-138°C
• 沸点：
  221.4±42.0 °C(Predicted)
• 密度：
  1.76±0.1 g/cm3(Predicted)
• 闪点：
  2 °C
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  92.3
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xn,F,Xi
• 危险类别码：
  R11
• 危险品运输编号：
  UN 1648 3
• WGK Germany：
  3
• 安全说明：
  S26,S36/37/39,S45
• 包装等级：
  III
• 危险类别：
  4.1
• 危险性防范说明：
  P240,P210,P241,P264,P280,P302+P352,P370+P378,P337+P313,P305+P351+P338,P362+P364,P332+P313
• 危险性描述：
  H315,H319,H228

制备方法与用途

化学性质：白色结晶，熔点为137-139℃。

用途：用作药物氟莫克西的侧链。

反应信息

• 作为反应物：
  描述：

  1-(2--羟乙基)-5-巯基-1H-四氮唑 在 bis(2-methoxyethyl) azodicarboxylate 、 三苯基膦 作用下， 以 四氢呋喃 为溶剂， 以32%的产率得到5,6-dihydrothiazolo[3.2-d]tetrazole
  参考文献：
  名称：

  BIS(2-ALKOXYETHYL) AZODICARBOXYLATE ESTER COMPOUND AND INTERMEDIATE FOR PRODUCTION OF THE SAME

  摘要：

  公开号：

  EP2112136B1
• 作为产物：
  描述：

  N-(2-羟基乙基)二硫代氨基甲酸甲酯 在 sodium azide 作用下， 以 乙醇 为溶剂， 反应 3.0h， 生成 1-(2--羟乙基)-5-巯基-1H-四氮唑
  参考文献：
  名称：

  具有四唑硫醚部分的新的1β-甲基卡巴宁的合成及其生物学性质。

  摘要：

  描述了一系列在吡咯烷的C-5位具有四唑硫醚部分的新的1β-甲基卡巴贝烯1a-1的合成和生物活性。在这些化合物中，与亚胺培南和美洛培南相比，1c具有最强的抗菌活性和先进的药代动力学。

  DOI：

  10.1016/s0960-894x(00)00253-5

文献信息

• 7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04205166A1

  公开（公告）日：1980-05-27

  Cephalosporanic acid derivatives and preparation thereof having the following formula ##STR1## wherein R.sub.1 is hydrogen or acyl, and R.sub.2 is aminoalkyl-, acylaminoalkyl-, sulfoalkylaminoalkyl-, or hydroxyalkyl-substituted, N- or N and S-containing heterocyclic groups.

  头孢菌素酸衍生物及其制备具有以下公式##STR1##其中R.sub.1为氢或酰基，R.sub.2为氨基烷基，酰胺基烷基，磺酰胺基烷基或羟基烷基取代的，含N或N和S的杂环基团。
• A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships.
  作者：MITSUO NUMATA、ISAO MINAMIDA、MASAYOSHI YAMAOKA、MITSURU SHIRAISHI、TOSHIO MIYAWAKI、HIROSHI AKIMOTO、KENZO NAITO、MAKOTO KIDA

  DOI：10.7164/antibiotics.31.1262

  日期：——

  The synthesis and the in vitro and in vivo antimicrobial activities of a series of 7-[2-(2-aminothiazol-4-yl)acetamido]cephalosporins (1) having varied 3-substituents, such as methyl, hydroxymethyl, acetoxymethyl, pyridiniomethyl and heterocyclicthiomethyls, are described. The derivatives having five membered heterocyclicthiomethyls exhibited strong inhibitory activities against Gram-negative organisms including some strains of Escherichia coli and Proteus morganii which are insensitive to cefazolin and cephaloridine. Pronounced activities were noted with 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid (1y; SCE-963).

  报道了一系列7-[2-(2-氨基噻唑-4-基)乙酰氨基]头孢菌素（1）的合成及其体外和体内的抗菌活性，这些化合物具有不同的3-取代基，如甲基、羟甲基、乙酰氧甲基、吡啶鎓甲基和杂环硫甲基等。含有五元杂环硫甲基的衍生物对包括某些对头孢唑林和头孢利定不敏感的大肠杆菌和摩根氏变形杆菌等革兰氏阴性菌表现出强烈的抑制活性。特别值得注意的是7-[2-(2-氨基噻唑-4-基)乙酰氨基]-3-[[[1-(2-二甲氨基乙基)-1H-四唑-5-基]硫]甲基]头孢-3-烯-4-羧酸（1y；SCE-963）显示了显著的活性。
• 3-Vinyl-cephalosporin derivatives
  申请人：Rhone-Poulenc Industries

  公开号：US04307233A1

  公开（公告）日：1981-12-22

  Novel 3-vinyl-cephalosporin derivates of the general formula ##STR1## in the bicyclooct-2-ene or bicyclooct-3-ene form, in which R.sub.1 is a protective radical or is a radical of the general formula ##STR2## in which R.sub.5 is hydrogen, alkyl, vinyl or cyanomethyl, or a protective radical, and R.sub.6 is hydrogen or a protective radical, and R.sub.2 is a protective radical or an enzymatically removable radical, or R.sub.1 is an acyl radical, which may carry various substituents, and R.sub.2 represents a protective radical, and R.sub.3 and R.sub.4, which are identical or different, represent alkyl (optionally substituted by hydroxyl, alkoxy, amino, alkylamino or dialkylamino) or phenyl, or form, together with the nitrogen atom, a saturated 5-membered or 6-membered heterocyclic ring optionally containing another hetero-atom, their E- and Z-forms and their mixtures, are useful as intermediates for the preparation of 3-thiovinyl cephalosporins useful as antibacterial agents.

  具有通式##STR1##的新型3-乙烯基头孢菌素衍生物，以双环辛-2-烯或双环辛-3-烯形式存在，其中R1为保护基团或具有通式##STR2##的基团，其中R5为氢、烷基、乙烯基或氰甲基，或为保护基团，R6为氢或保护基团，R2为保护基团或酶可去除的基团，或R1为可带有各种取代基的酰基基团，R2表示保护基团，R3和R4相同或不同，表示烷基（可被羟基、烷氧基、氨基、烷基氨基或二烷基氨基取代）或苯基，或与氮原子一起形成含有另一个杂原子的饱和5元或6元杂环环，它们的E型和Z型及其混合物，可作为制备作为抗菌剂有用的3-硫代乙烯基头孢菌素的中介体。
• Cephalosporin derivatives
  申请人：Rhone-Poulenc Industries

  公开号：US04034090A1

  公开（公告）日：1977-07-05

  New cephalosporin derivatives of the formula: ##STR1## in which either (a) R.sub.1 is hydrogen, acetoxy, azido or heterocyclylthio or heterocyclylcarbonylthio which is (1,3,4-thiadiazol-2-yl)-thio which is unsubstituted or substituted by straight or branched chain C.sub.1-4 alkyl or alkoxy, straight or branched chain C.sub.1-4 alkylthio, straight or branched chain C.sub.1-4 alkylsulphonyl, amino or acetylamino; (1,2,3,4-tetrazol-5-yl)-thio which is unsubstituted or substituted in the 1-position by straight or branched chain C.sub.1-4 alkyl, hydroxy straight or branched chain C.sub.1-4 alkyl, phenyl or hydroxyphenyl, or in the 2-position by straight or branched chain C.sub.1-4 alkyl or hydroxy straight or branched chain C.sub.1-4 alkyl; (1,2,4-triazol-3-yl)-thio, (4-methyl-1,3-thiazol-2-yl)-thio, (3-methyl-1,2,4-thiadiazol-5-yl)-thio or (1,2,3-thiadiazol-4-yl)-carbonylthio, and R.sub.2 is carboxy or a radical of the formula: ##STR2## in which the radical: ##STR3## is a radical which can be easily removed enzymatically, and in which R.sub.3 is hydrogen or straight or branched chain C.sub.1-4 alkyl and R.sub.4 is straight or branched chain C.sub.1-4 alkyl or cyclohexyl; or (b) R.sub.1 is a pyridinio ion and R.sub.2 is a carboxylato ion, and pharmaceutically acceptable non-toxic metal salts thereof and addition salts thereof with nitrogen containing bases possess valuable anti-bacterial properties, showing activity against both Gram-positive and Gram-negative bacteria.

  新型头孢菌素衍生物的通式为：##STR1## 其中，(a) R1为氢、乙酸氧、叠氮或杂环硫或杂环羰基硫，具体为未取代或被直链或支链C1-4烷基或烷氧基、直链或支链C1-4烷基硫、直链或支链C1-4烷基磺酰基、氨基或乙酰氨基取代的(1,3,4-噻二唑-2-基)硫；未取代或1位被直链或支链C1-4烷基、羟基直链或支链C1-4烷基、苯基或羟基苯基取代，或2位被直链或支链C1-4烷基或羟基直链或支链C1-4烷基取代的(1,2,3,4-四唑-5-基)硫；(1,2,4-三唑-3-基)硫、(4-甲基-1,3-噻唑-2-基)硫、(3-甲基-1,2,4-噻二唑-5-基)硫或(1,2,3-噻二唑-4-基)羰基硫，R2为羧基或以下通式所示的基团：##STR2## 其中，##STR3## 是一个可被酶轻易移除的基团，R3为氢或直链或支链C1-4烷基，R4为直链或支链C1-4烷基或环己基；或(b) R1为吡啶鎓离子，R2为羧基离子，以及其药用可接受的非毒性金属盐和与含氮碱形成的加成盐，具有宝贵的抗菌特性，对革兰氏阳性和革兰氏阴性细菌均显示出活性。
• Carbapenem and penem antibiotics. II. Synthesis and antibacterial activity of 2-functionalized-methyl carbapenems related to asparenomycins.
  作者：MITSURU IMUTA、HISAO ONA、SHOICHIRO UYEO、KIYOSHI MOTOKAWA、TADASHI YOSHIDA

  DOI：10.1248/cpb.33.4361

  日期：——

  Racemic 2-acetoxymethyl and 2-(heteroaromatic) thiomethyl carbapenems having a 1-(hydroxymethyl) ethylidene or cyclic carbonate side-chain at C-6 (5, 25, 38, 40, 42, and 36b, 23b, 28b, 30b, 32b, 34b) were synthesized from the common intermediates 3a and 3b, and their antibacterial activities were determined.

  具有C-6位的1-(羟甲基)亚乙基或环状碳酸酯侧链的Racemic 2-乙酰氧甲基和2-(杂芳基)硫甲基碳青霉烯化合物（5、25、38、40、42和36b、23b、28b、30b、32b、34b）通过共同中间体3a和3b合成，并测定了它们的抗菌活性。